HIPK2 is downregulated by hypoxia and by hyperglycemia [48,49] (the latter being a common feature of diabetes mellitus), two conditions often present in solid tumors, including colon cancer, and having a role in cancer progression and resistance to therapies [5,50,51]. This evidence concerns the gene HIPK2 and malignant colon neoplasm.